Sensitive assessment of cytostatic drug resistance-mediating factors MDR1 and MRP in tumors of the gastrointestinal tract by RT-PCR

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 1, 1998, Pages 55-57

  Reymann, A ^a   Woermann, C ^a   Froschle G ^a   Schneider, C ^a   Brasen J H ^a   Lage, H ^b   Dietel, M ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSTATIC AGENT; MULTIDRUG RESISTANCE PROTEIN;

ADULT; AGED; CONFERENCE PAPER; DIGESTIVE SYSTEM CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; FEMALE; GASTROINTESTINAL NEOPLASMS; GENES, MDR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 0031972793     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Baldini N, Scotlandi K, Barbanti-Bodano G, Manara MC, Maurici D, Bacci G, Bertoni F, Picci P, Sottili S, Campanacci M, Serra M 1995 Expression of P-glycoprotein in high grade osteosarcomas in relation to clinical outcome. N Engl J Med 333: 1380-1385
2. Bargou RC, Jürchott K, Wagener C, Bergmann S, Metzner S, Bommert K, Mapara MY, Winzer KJ, Dietel M, Dörken B, Royer HD 1997 Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic mdr1 gene expression. Nature Med 3: 447-450
3. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist AJ, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG 1992 Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654
4. Gekeler V, Beck J, Wilisch A, Frese G, Neumann M, Handgretinger R, Ehninger G, Probst H, Niethammer D 1994 Drug-induced changes in the expression of MDR associated genes: Investigations on cultured cell lines and chemotherapeutically treated leukemias. Ann Hematol 69: S19-S24
5. Kaye SB 1997 Multidrug resistance in breast cancer - is the jury in yet? J Natl Cancer Inst 89: 902-903
6. Läer S, Bunge A, Dietel M, Meyer-Pannwitt U, Schaefer A, Trapp M, Woermann C, Reymann A 1996 Human leukemia cells lines K562-RADR express low levels of P-glycoprotein-mediated multidrug reistance. Reference for clinical tumor specimen. In: Kuhlmann J, Klotz U (eds) Clinical Pharmacology (Vol 14). Zuckschwerdt, München, pp 68-76
7. Lautier D, Canitrot Y, Deeley RG, Cole SPC 1996 Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem Pharmacol 52: 967-977
8. Murren JR, Hait WN 1992 Why haven't we cured multidrug-resistant tumors? Oncol Res 4: 1-6
9. Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL, Haber M 1996 Expression of the gene for multidrug resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med 334: 231-238
10. Raderer M, Scheithauer W 1993 Clinical trials of agents that reverse multidrug resistance. Cancer 72: 3553-3563
11. Weinstein RS, Jakate SM, Dominguez JM, Lebowitz MD, Koukoulis GK, Kuszak JR, Klusens LF, Grogan TM, Saclarides TJ, Roninson IB, Coon JS 1991 Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 51: 2720-2726
12. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace jr AJ, Kohn KW, Fojo AT, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharewitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE, Paull KD 1997 An information-intensive approach to the molecular pharmacology of cancer. Science 275: 343-349